Literature DB >> 2852724

Increase of cyclic AMP in subcellular fractions of rat heart muscle after beta-adrenergic stimulation: prenalterol and isoprenaline caused different distribution of bound cyclic AMP.

H Aass1, T Skomedal, J B Osnes.   

Abstract

Although prenalterol is a partial beta-agonist, it has been reported to produce only a marginal, non-significant increase of cAMP in rat hearts. We studied the effect of prenalterol and isoprenaline on free and bound cAMP content in subcellular fractions of perfused rat hearts to see whether prenalterol increased cAMP and whether there were differences in the subcellular distribution of the cAMP contents after stimulation with the drugs. The in situ binding characteristics of cAMP to the protein kinases at different degree of beta-adrenergic stimulation were elucidated. Prenalterol increased significantly both total cAMP content in homogenate, bound cAMP in a 100,000 g particulate fraction and bound, free and total cAMP contents in the resulting supernatant. While prenalterol increased bound cAMP in the particulate fraction and in the supernatant proportionally, isoprenaline caused a relatively greater increase of bound cAMP in the supernatant. At equieffective concentrations regarding inotropic and lusitropic effects, prenalterol and isoprenaline increased bound cAMP in the particulate fraction to the same degree, while the increase in the other fractions was greater after isoprenaline. Thus, the cAMP bound in the particulate fraction seemed to determine the inotropic state of the cell after beta-adrenergic stimulation, supporting a compartmentation of cAMP in myocardium. In controls 31 to 34% of the total binding capacity for cAMP in the particulate fraction was occupied, increasing to 77% after maximal beta-stimulation. The binding capacity in the supernatant was only 15 to 18% saturated in the basal situation and about half saturated after maximal beta-stimulation. cAMP bound in the particulate fraction is of special interest when cAMP and functional effects are studied.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852724     DOI: 10.1016/s0022-2828(88)80009-9

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  11 in total

Review 1.  Protein phosphorylation and compartments of cyclic AMP in the control of cardiac contraction.

Authors:  K J Murray; M L Reeves; P J England
Journal:  Mol Cell Biochem       Date:  1989-09-07       Impact factor: 3.396

Review 2.  A-kinase anchoring proteins: a key to selective activation of cAMP-responsive events?

Authors:  V M Coghlan; S E Bergeson; L Langeberg; G Nilaver; J D Scott
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

3.  In-vivo phosphorylation of the cardiac L-type calcium channel beta-subunit in response to catecholamines.

Authors:  H Haase; S Bartel; P Karczewski; I Morano; E G Krause
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

4.  Compartmentation of cAMP signaling in cardiac myocytes: a computational study.

Authors:  Radu V Iancu; Stephen W Jones; Robert D Harvey
Journal:  Biophys J       Date:  2007-02-09       Impact factor: 4.033

5.  Beta2-adrenergic receptor overexpression in the developing mouse heart: evidence for targeted modulation of ion channels.

Authors:  R An; B M Heath; J P Higgins; W J Koch; R J Lefkowitz; R S Kass
Journal:  J Physiol       Date:  1999-04-01       Impact factor: 5.182

6.  The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte.

Authors:  H M Piper; B C Millar; B J McDermott
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

7.  The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure.

Authors:  S B Liggett; L E Wagoner; L L Craft; R W Hornung; B D Hoit; T C McIntosh; R A Walsh
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

8.  cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists.

Authors:  J Jurevicius; R Fischmeister
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Investigating β-adrenergic-induced cardiac hypertrophy through computational approach: classical and non-classical pathways.

Authors:  Ali Khalilimeybodi; Alireza Daneshmehr; Babak Sharif-Kashani
Journal:  J Physiol Sci       Date:  2017-07-03       Impact factor: 2.781

10.  Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals.

Authors:  Aniella Abi-Gerges; Wito Richter; Florence Lefebvre; Philippe Mateo; Audrey Varin; Christophe Heymes; Jane-Lise Samuel; Claire Lugnier; Marco Conti; Rodolphe Fischmeister; Grégoire Vandecasteele
Journal:  Circ Res       Date:  2009-09-10       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.